EUTM reform – the sequel

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EUTM reform – the sequel

Fans of the EU trade mark (EUTM) will all have enjoyed last year’s trade mark reform package, which starred the notorious Section 28(8) declarations. But did you know that the sequel is released on October 1 this year, and will feature changes affecting examination, oppositions and appeals?

This article is brought to you by our Trademark Times 2017 sponsors:




The trailer for “EUTM reform – the sequel” was adopted by the European Commission last Thursday, in the form of the Commission Implementing Regulation and Commission Delegated Regulation. These are due to be published officially by the end of July and will apply from October 1.

This so-called secondary legislation sets out the rules for the reforms that come into effect on that date, as Tomás Eichenberg of the European Commission explained in a session at the INTA Annual Meeting yesterday.

Of most immediate interest to trademark applicants will likely be the new rules on how to apply for non-traditional trademarks following the abolition of the graphical representation requirement. Eichenberg said the rules are designed to provide “flexibility” explaining: “You can still represent your trademark graphically.” EUIPO has provided guidance on formats that will be accepted (see illustration).

He added that the Delegated Regulation will promote consistency: “It will make office procedures more predictable.” Also on May 17, as part of a codification exercise, the Commission approved a final text for the EUTM Regulation, which comprises 212 articles. That text, which Eichenberg described as “an important new piece of legislation”, is expected to be published in the next few weeks.

The EUIPO is already working on a new version of its Guidelines, taking into account the changes coming in October, and a draft was published last week, as Michael Hawkins of Noerr explained. These address everything from the procedural changes to fee amounts, the renewal date and the filing of priority claims through to the written evidence requirements and the new EU certification mark. An important change, said Hawkins, is that acquired distinctiveness through use may be invoked as a subsidiary claim. “That will hopefully allow the case to be heard first on inherent distinctiveness and if that doesn’t succeed then on acquired distinctiveness,” he said.

There are also important reforms to opposition, cancellation and appeal proceedings, said Hawkins: “There are some interesting changes at all levels of the Office.”

If all that does not sate your appetite for trademark reform, then András Jókutí of the Hungarian IP Office previewed the next instalment, which will see national offices implementing the changes required by the EU Trade Mark Directive over the next few years.

more from across site and SHARED ros bottom lb

More from across our site

New timeline for 2026 aims to provide clearer guidance to firms and practitioners on the full jurisdictional market view
Attorneys contemplate whether clients using AI for legal guidance is beneficial to attorney-client relationships or more of a nuisance
Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Gift this article